Moneycontrol PRO

Cipla — Large part of COVID opportunity has played out

In the US market, Albuterol opportunity remains a key lever for Cipla at least till the time Perrigo re-enters although in terms of market share, the drugmaker may be close to maturity

January 31, 2021 / 01:23 PM IST
Cipla — Large part of COVID opportunity has played out

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights - Strong performance led by India - In US, Albuterol gains are offset by a product recall -Next drug to watch is Advair, used in the management of pulmonary disease - Margins likely to moderate as operating expenses pick up Cipla (CMP: Rs 826; Market cap: Rs 66,606 crore) — the world’s second largest seller of inhalers — has posted another strong quarter, helped by its respiratory portfolio. The resultant cash flow has helped the company repay loan worth $137 million ahead of schedule and Rs...

  • PRO Panorama

    Moneycontrol Pro Panorama | Banking crisis: Will Powell pause?

    Mar 22, 2023 / 03:09 PM IST

    In today’s edition of Moneycontrol Pro Panorama: India likely to maintain growth momentum, gold is back in the limelight, China'...

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender: Between the Fed and a hard place

    Mar 11, 2023 / 11:38 AM IST

    The Fed is caught between combating inflation and worries over a financial mishap

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers